51. Aberrant expression of the transcriptional factor Twist1 promotes invasiveness in ALK-positive anaplastic large cell lymphoma
- Author
-
Fang Wu, Mary M. Hitt, Todd P. W. McMullen, Jingdong Zhang, Robert J. Ingham, Matthew D. Li, David Sharon, Raymond Lai, and Peng Wang
- Subjects
STAT3 Transcription Factor ,medicine.medical_specialty ,animal structures ,Src Homology 2 Domain-Containing, Transforming Protein 1 ,medicine.drug_class ,Pyridines ,Blotting, Western ,Biology ,medicine.disease_cause ,03 medical and health sciences ,0302 clinical medicine ,Crizotinib ,Piperidines ,hemic and lymphatic diseases ,Internal medicine ,Cell Line, Tumor ,medicine ,Anaplastic lymphoma kinase ,Humans ,Neoplasm Invasiveness ,Epithelial–mesenchymal transition ,Anaplastic large-cell lymphoma ,Protein kinase B ,030304 developmental biology ,Cell Proliferation ,0303 health sciences ,Reverse Transcriptase Polymerase Chain Reaction ,Large cell ,Twist-Related Protein 1 ,Nuclear Proteins ,Cell Biology ,Protein-Tyrosine Kinases ,medicine.disease ,Immunohistochemistry ,ALK inhibitor ,Gene Expression Regulation, Neoplastic ,Endocrinology ,Shc Signaling Adaptor Proteins ,030220 oncology & carcinogenesis ,Gene Knockdown Techniques ,Cancer research ,Lymphoma, Large-Cell, Anaplastic ,Pyrazoles ,Carcinogenesis ,Proto-Oncogene Proteins c-akt ,medicine.drug ,Signal Transduction - Abstract
The transcriptional factor Twist1 has been shown to play a key role in regulating epithelial mesenchymal transition, invasiveness and migratory properties in solid tumors. We found that Twist1 is aberrantly expressed in ALK-positive anaplastic large cell lymphoma (ALK+ALCL), a type of T-cell lymphoid malignancy. Using RT-PCR and Western blots, Twist1 was detectable in all 3 ALK+ALCL cell lines examined but absent in normal T-cells. By immunohistochemistry, Twist1 was detectable in all 10 cases of ALK+ALCL examined; benign lymphoid tissues were consistently negative. Twist1 expression in ALK+ALCL cells can be attributed to the NPM-ALK/STAT3 signaling axis, the key oncogenic driving force in this tumor type. Twist1 is biologically important in ALK+ALCL cells, as Twist1 knockdown resulted in a significant decrease in their invasiveness in an in-vitro assay. Further investigation revealed that this increase in invasiveness is linked to the activation of AKT and down-regulation of p66Shc, two signaling proteins known to be involved in NPM-ALK-mediated oncogenesis. Lastly, knockdown of Twist1 sensitizes ALK+ALCL cells to the growth inhibitory effect of PF-2341066 (Crizotinib®), an ALK inhibitor being used in clinical trials. In conclusion, Twist1 expression, owing to the abnormal NPM-ALK/STAT3 signaling, contributes to its invasiveness and decreased sensitivity to PF-2341066 in ALK+ALCL.
- Published
- 2011